Skip to Content

9,677 Results Found

  • Review
  • Open Access
54 Citations
11,907 Views
15 Pages

The balance between anabolism and catabolism is disrupted with aging, with the rate of anabolism being faster than that of catabolism. Therefore, mTOR, whose major function is to enhance anabolism and inhibit catabolism, has become a potential target...

  • Review
  • Open Access
12 Citations
8,256 Views
22 Pages

A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy

  • Rose Parisi,
  • Hemali Shah,
  • Neil H. Shear,
  • Michael Ziv and ,
  • Alina Markova and
  • Roni P. Dodiuk-Gad
  • + 1 author+ 0 author

The rapid evolution of anti-cancer therapy (including chemotherapy, targeted therapy, and immunotherapy) in recent years has led to a more favorable efficacy and safety profile for a growing cancer population, and the improvement of overall survival...

(This article belongs to the Special Issue Hypersensitivity to Drugs and Vaccines: Molecular Basis and Translational Research)
  • Review
  • Open Access
4 Citations
4,452 Views
22 Pages

Despite the development of a wide plethora of different anticancer agents, most of them are not used for patient treatment due to adverse effects caused by untargeted cytotoxicity. To prevent this unwanted toxicity, it is necessary to develop therapi...

(This article belongs to the Special Issue Targeted Therapy of Cancer: Innovative Drugs and Molecular Tools)
  • Opinion
  • Open Access
11 Citations
5,464 Views
11 Pages

15 January 2025

As a ubiquitous human pathogen, the Epstein–Barr virus (EBV) has established lifelong persistent infection in about 95% of the adult population. The EBV infection is associated with approximately 200,000 human cancer cases and 140,000 deaths pe...

(This article belongs to the Special Issue Epigenetic and Transcriptional Regulation of DNA Virus Infections)
  • Review
  • Open Access
31 Citations
8,511 Views
29 Pages

Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy

  • Minhyuk Lee,
  • Minjae Lee,
  • Youngseo Song,
  • Sungjee Kim and
  • Nokyoung Park

7 October 2024

Nucleic acid therapeutics are promising alternatives to conventional anti-cancer therapy, such as chemotherapy and radiation therapy. While conventional therapies have limitations, such as high side effects, low specificity, and drug resistance, nucl...

(This article belongs to the Special Issue Advances in Targeted Delivery of Nanomedicines)
  • Review
  • Open Access
1 Citations
1,713 Views
22 Pages

Computational Methods in Anti-Cancer Drug Discovery, Development, and Therapy Management: A Review

  • Jingyi Liu,
  • Jiaer Cai,
  • Jingyue Yao,
  • Yufan Liu and ,
  • Xin Lu and
  • Chao Zhao
  • + 1 author+ 0 author

21 April 2026

Cancer has become a major global health threat due to its high incidence and mortality. However, the development of anti-cancer drugs is limited by high costs, long cycles, and low success rates, slowing the progress of new treatments. As a method th...

  • Review
  • Open Access
16 Citations
6,929 Views
25 Pages

Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects

  • Jesús I. Gil-Chinchilla,
  • Agustín G. Zapata,
  • Jose M. Moraleda and
  • David García-Bernal

21 June 2024

Mesenchymal stem/stromal cells (MSCs) are one of the most widely used cell types in advanced therapies due to their therapeutic potential in the regulation of tissue repair and homeostasis, and immune modulation. However, their use in cancer therapy...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
66 Citations
17,168 Views
30 Pages

The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies

  • Haochuan Guo,
  • Xinru Xu,
  • Jiaxi Zhang,
  • Yajing Du and ,
  • Xinbing Yang,
  • Zhiheng He,
  • Linjie Zhao,
  • Tingming Liang and
  • Li Guo
  • + 4 authors+ 0 author

9 August 2024

The establishment and utilization of preclinical animal models constitute a pivotal aspect across all facets of cancer research, indispensably contributing to the comprehension of disease initiation and progression mechanisms, as well as facilitating...

(This article belongs to the Special Issue Adjuvant Therapies for Cancer Treatment)
  • Review
  • Open Access
50 Citations
6,058 Views
19 Pages

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review

  • Richard F. Riedel,
  • Robin L. Jones,
  • Antoine Italiano,
  • Chet Bohac and ,
  • Juliette C. Thompson,
  • Kerstin Mueller,
  • Zaeem Khan,
  • Seth M. Pollack and
  • Brian A. Van Tine
  • + 4 authors+ 0 author

1 November 2018

Synovial sarcoma (SS) is an aggressive malignancy which accounts for approximately 5–10% of all soft-tissue sarcomas. SS has pathologic and genomic characteristics that define it as a distinct subtype of soft tissue sarcoma (STS). STS subtypes contin...

  • Review
  • Open Access
39 Citations
5,853 Views
16 Pages

Effect of Flow-Induced Shear Stress in Nanomaterial Uptake by Cells: Focus on Targeted Anti-Cancer Therapy

  • Samar Shurbaji,
  • Gulsen G. Anlar,
  • Essraa A. Hussein,
  • Ahmed Elzatahry and
  • Huseyin C. Yalcin

16 July 2020

Recently, nanomedicines have gained a great deal of attention in diverse biomedical applications, including anti-cancer therapy. Being different from normal tissue, the biophysical microenvironment of tumor cells and cancer cell mechanics should be c...

(This article belongs to the Special Issue Cancer Nanomedicine)
  • Review
  • Open Access
9 Citations
5,249 Views
18 Pages

Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know

  • Matthew D. Robinson,
  • Mairéad G. McNamara,
  • Hamish W. Clouston,
  • Paul A. Sutton and ,
  • Richard A. Hubner and
  • Juan W. Valle
  • + 1 author+ 0 author

26 July 2023

As part of routine cancer care, patients may undergo elective surgery with the aim of long-term cure. Some of these patients will receive systemic anti-cancer therapy (SACT) in the neoadjuvant and adjuvant settings. The majority of patients, usually...

  • Review
  • Open Access
34 Citations
7,077 Views
33 Pages

Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy

  • Hicham Wahnou,
  • Riad El Kebbaj,
  • Soufyane Hba,
  • Zaynab Ouadghiri and ,
  • Othman El Faqer,
  • Aline Pinon,
  • Bertrand Liagre,
  • Youness Limami and
  • Raphaël Emmanuel Duval
  • + 4 authors+ 0 author

5 April 2025

Neutrophils, the most abundant white blood cells, play a dual role in cancer progression. While they can promote tumor growth, metastasis, and immune suppression, they also exhibit anti-tumorigenic properties by attacking cancer cells and enhancing i...

(This article belongs to the Special Issue The Role of Neutrophils in Tumor Progression and Metastasis)
  • Review
  • Open Access
15 Citations
4,158 Views
15 Pages

Skin Malignancies Due to Anti-Cancer Therapies

  • Michela Starace,
  • Luca Rapparini and
  • Stephano Cedirian

22 May 2024

Skin cancers involve a significant concern in cancer therapy due to their association with various treatment modalities. This comprehensive review explores the increased risk of skin cancers linked to different anti-cancer treatments, including class...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
39 Citations
8,121 Views
27 Pages

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response

  • Elisa C. Toffoli,
  • Abdolkarim Sheikhi,
  • Yannick D. Höppner,
  • Pita de Kok and ,
  • Mahsa Yazdanpanah-Samani,
  • Jan Spanholtz,
  • Henk M. W. Verheul,
  • Hans J. van der Vliet and
  • Tanja D. de Gruijl
  • + 4 authors+ 0 author

9 February 2021

Natural Killer (NK) cells are innate immune cells with the unique ability to recognize and kill virus-infected and cancer cells without prior immune sensitization. Due to their expression of the Fc receptor CD16, effector NK cells can kill tumor cell...

(This article belongs to the Special Issue Challenges and Opportunities for Effective Cancer Immunotherapies)
  • Review
  • Open Access
908 Views
5 Pages

p53-Based Anti-Cancer Therapies: An Empty Promise?

  • Nikolas Desilet,
  • Tessa N. Campbell and
  • Francis Y.M. Choy

16 November 2009

Since its discovery in 1979, p53 has become the focus of intensive cancer-based research in laboratories around the world. The p53 protein mediates critical cellular functions including the response to genotoxic stress, differentiation, senescence, a...

  • Review
  • Open Access
8 Citations
13,045 Views
20 Pages

Thyroid cancer prevalence has increased in the last few decades. Whereas the majority of well-differentiated histotypes have effective therapeutic options, the most advanced cases lacked successful treatment until recent years. Genomic alterations ha...

(This article belongs to the Section Molecular Pharmacology)
  • Review
  • Open Access
51 Citations
9,786 Views
24 Pages

12 January 2023

Non-steroidal anti-inflammatory drugs (NSAIDs) express anti-tumoral activity mainly by blocking cyclooxygenase-2 involved in the synthesis of prostaglandins. Therefore, in the last few decades, many have attempted to explore the possibilities of appl...

(This article belongs to the Special Issue Drug Repurposing and Reformulation for Cancer Treatment)
  • Review
  • Open Access
63 Citations
11,124 Views
18 Pages

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

  • Tina Bøgelund Kristensen,
  • Malin L. T. Knutsson,
  • Markus Wehland,
  • Britt Elmedal Laursen and ,
  • Daniela Grimm,
  • Elisabeth Warnke and
  • Nils E. Magnusson
  • + 2 authors+ 0 author

11 December 2014

Neo-angiogenesis is a critical process for tumor growth and invasion and has become a promising target in cancer therapy. This manuscript reviews three currently relevant anti-angiogenic agents targeting the vascular endothelial growth factor system:...

(This article belongs to the Special Issue Advances in Proteomic Research)
  • Review
  • Open Access
68 Citations
12,555 Views
27 Pages

Biomarkers for Anti-Angiogenic Therapy in Cancer

  • Markus Wehland,
  • Johann Bauer,
  • Nils E. Magnusson,
  • Manfred Infanger and
  • Daniela Grimm

29 April 2013

Angiogenesis, the development of new vessels from existing vasculature, plays a central role in tumor growth, survival, and progression. On the molecular level it is controlled by a number of pro- and anti-angiogenic cytokines, among which the vascul...

(This article belongs to the Special Issue Advances in Cancer Diagnosis)
  • Feature Paper
  • Review
  • Open Access
2 Citations
3,482 Views
48 Pages

Nowadays, due to improvements in living standards, more attention is reserved to all-around disease prevention and health care. In particular, research efforts have been made for developing novel methods and treatments for anti-cancer therapy. Self-p...

  • Article
  • Open Access
2 Citations
1,649 Views
17 Pages

Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer

  • Hajime Matsuida,
  • Kosaku Mimura,
  • Shotaro Nakajima,
  • Katsuharu Saito and ,
  • Sohei Hayashishita,
  • Chiaki Takiguchi,
  • Azuma Nirei,
  • Tomohiro Kikuchi,
  • Hiroyuki Hanayama and
  • Koji Kono
  • + 9 authors+ 4 authors

6 August 2025

Background: Anti-programmed death 1 receptor (PD-1) therapy is a promising treatment strategy for patients with unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer. However, its response rate and survival benefits are...

(This article belongs to the Special Issue Gastrointestinal Cancer: From Cellular and Molecular Mechanisms to Therapeutic Opportunities)
  • Article
  • Open Access
10 Citations
3,438 Views
12 Pages

A Novel N-Tert-Butyl Derivatives of Pseudothiohydantoin as Potential Target in Anti-Cancer Therapy

  • Daria Kupczyk,
  • Renata Studzińska,
  • Szymon Baumgart,
  • Rafał Bilski and ,
  • Tomasz Kosmalski,
  • Renata Kołodziejska and
  • Alina Woźniak
  • + 2 authors+ 0 author

29 April 2021

Tumors are currently more and more common all over the world; hence, attempts are being made to explain the biochemical processes underlying their development. The search for new therapeutic pathways, with particular emphasis on enzymatic activity an...

(This article belongs to the Special Issue Anticancer Drug Discovery and Development)
  • Review
  • Open Access
19 Citations
6,761 Views
25 Pages

Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier

  • Carolin J. Curtaz,
  • Ludwig Kiesel,
  • Patrick Meybohm,
  • Achim Wöckel and
  • Malgorzata Burek

19 October 2022

The molecular receptor status of breast cancer has implications for prognosis and long-term metastasis. Although metastatic luminal B-like, hormone-receptor-positive, HER2−negative, breast cancer causes brain metastases less frequently than oth...

(This article belongs to the Special Issue Brain Metastasis in Breast Cancer)
  • Review
  • Open Access
45 Citations
7,317 Views
28 Pages

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology

  • Stefania Crisci,
  • Filomena Amitrano,
  • Mariangela Saggese,
  • Tommaso Muto and ,
  • Sabrina Sarno,
  • Sara Mele,
  • Pasquale Vitale,
  • Giuseppina Ronga,
  • Massimiliano Berretta and
  • Raffaele Di Francia
  • + 5 authors+ 0 author

28 July 2019

The upgraded knowledge of tumor biology and microenviroment provides information on differences in neoplastic and normal cells. Thus, the need to target these differences led to the development of novel molecules (targeted therapy) active against the...

  • Article
  • Open Access
9 Citations
4,005 Views
17 Pages

Surface initiated atom transfer radical polymerization (SI-ATRP) documented a simple but efficient technique to grow a dense polymer layer on any surface. Gold nanoparticles (AuNPs) give a broad surface to immobilize sulfhyryl group-containing initia...

  • Review
  • Open Access
16 Citations
6,431 Views
13 Pages

An adequate blood supply is essential for cancer cells to survive and grow; thus, the concept of inhibiting tumor angiogenesis has been applied to cancer therapy, and several drugs are already in clinical use. It has been shown that treatment with th...

(This article belongs to the Special Issue Tumor Microenvironment)
  • Review
  • Open Access
7 Citations
3,230 Views
16 Pages

Recent Advances in Combination Therapy of YAP Inhibitors with Physical Anti-Cancer Strategies

  • Junchi Zhou,
  • Changyan Yu,
  • Wanhong Yang,
  • Nian Jiang and ,
  • Sanhua Li,
  • Yun Liu and
  • Xinting Zhu
  • + 2 authors+ 0 author

29 June 2025

In recent years, physical anti-cancer strategies using radiation, light, sound, electricity, and magnetism have shown great potential in cancer treatment. Photodynamic therapy, radiation therapy, photothermal therapy, and other treatments have differ...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
74 Citations
9,656 Views
32 Pages

MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies

  • Hyun Ah Seo,
  • Sokviseth Moeng,
  • Seokmin Sim,
  • Hyo Jeong Kuh and ,
  • Soo Young Choi and
  • Jong Kook Park
  • + 1 author+ 0 author

20 December 2019

The susceptibility of cancer cells to different types of treatments can be restricted by intrinsic and acquired therapeutic resistance, leading to the failure of cancer regression and remission. To overcome this problem, a combination therapy has bee...

(This article belongs to the Special Issue microRNA as Therapeutic Target)
  • Review
  • Open Access
8 Citations
6,223 Views
17 Pages

The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?

  • Manikandan Muthu,
  • Sechul Chun,
  • Judy Gopal,
  • Gyun-Seok Park and ,
  • Arti Nile,
  • Jisoo Shin,
  • Juhyun Shin,
  • Tae-Hyoung Kim and
  • Jae-Wook Oh
  • + 4 authors+ 0 author

Despite multitudes of reports on cancer remedies available, we are far from being able to declare that we have arrived at that defining anti-cancer therapy. In recent decades, researchers have been looking into the possibility of enhancing cell death...

(This article belongs to the Special Issue Recent Advances of Proteomics Applied to Cancer and Human Diseases)
  • Feature Paper
  • Review
  • Open Access
257 Citations
13,598 Views
30 Pages

24 December 2019

Heat shock proteins (HSPs) constitute a large family of molecular chaperones classified by their molecular weights, and they include HSP27, HSP40, HSP60, HSP70, and HSP90. HSPs function in diverse physiological and protective processes to assist in m...

(This article belongs to the Special Issue Molecular Chaperones: Cancer and Cell Death)
  • Article
  • Open Access
20 Citations
3,982 Views
19 Pages

Synthesis and Design of Purpurin-18-Loaded Solid Lipid Nanoparticles for Improved Anticancer Efficiency of Photodynamic Therapy

  • Sooho Yeo,
  • Hyeon Ho Song,
  • Min Je Kim,
  • Seokhyeon Hong and ,
  • Il Yoon and
  • Woo Kyoung Lee
  • + 1 author+ 0 author

Purpurin-18 (P18) is one of the essential photosensitizers used in photodynamic therapy (PDT), but its hydrophobicity causes easy coalescence and poor bioavailability. This study aimed to synthesize P18 and design P18-loaded solid lipid nanoparticles...

(This article belongs to the Topic Targeting Tumor Metabolism for Cancer Therapy)
  • Review
  • Open Access
6 Citations
5,211 Views
21 Pages

Evaluation of Anti-Angiogenic Therapy Combined with Immunotherapy and Chemotherapy as a Strategy to Treat Locally Advanced and Metastatic Non-Small-Cell Lung Cancer

  • Mahmoud Abdallah,
  • Rick Voland,
  • Malcolm Decamp,
  • John Flickinger and ,
  • Toni Pacioles,
  • Muhammad Jamil,
  • Damian Silbermins,
  • Mina Shenouda,
  • Matias Valsecchi and
  • John Varlotto
  • + 15 authors+ 10 authors

17 December 2024

Immunotherapy has made recent improvements in disease-free survival (DFS) and/or overall survival (OS) in all stages of non-small-cell lung cancer (NSCLC). Here, we review the tumor microenvironment and its immunosuppressive effects and discuss how a...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
3,832 Views
13 Pages

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

  • Yien Ning Sophia Wong,
  • Christopher C. T. Sng,
  • Diego Ottaviani,
  • Grisma Patel and ,
  • Amani Chowdhury,
  • Irina Earnshaw,
  • Alasdair Sinclair,
  • Eve Merry,
  • Anjui Wu and
  • Alvin J. X. Lee
  • + 11 authors+ 6 authors

2 December 2021

An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients with solid cancer comparing the first and second waves of COVID-19. A retrospective analysis e...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
2 Citations
4,903 Views
22 Pages

Gut Bacteria-Based Cancer Therapy and Anti-Solid Tumor Mechanisms

  • Tianzhu Zhang,
  • Xiao-Mei Yu,
  • Shang-Tian Yang and
  • Wen-Wen Zhou

Cancer constitutes a significant global health challenge, ranking among the leading contributors to worldwide mortality. The inherent limitations of conventional oncologic interventions, particularly their frequent inability to induce durable remissi...

  • Review
  • Open Access
1 Citations
1,066 Views
29 Pages

Unravelling the Intricate Mechanism of Cucurbitacin-Mediated Anti-Cancer Therapy

  • Kankipati Sravya,
  • Shinde Kanchan Pramod Sangeeta,
  • Manash Kumar Paul and
  • Subhadip Mukhopadhyay

18 July 2026

Cancer continues to be a primary cause of death globally, necessitating the constant development of effective and less toxic therapeutics. Cucurbitacins belong to the tetracyclic triterpenoids found mainly in the Cucurbitaceae family. Cucurbitaceae p...

(This article belongs to the Section Cancer Drug Development)
  • Article
  • Open Access
15 Citations
4,170 Views
18 Pages

Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins

  • Hyejin Kim,
  • Inkyung Jung,
  • Chan Hyeong Lee,
  • Jungeun An and
  • Myunggon Ko

15 November 2023

Epigenetic dysregulation, particularly alterations in DNA methylation and hydroxymethylation, plays a pivotal role in cancer initiation and progression. Ten-eleven translocation (TET) proteins catalyze the successive oxidation of 5-methylcytosine (5m...

(This article belongs to the Special Issue Molecular Mechanism of Leukemia 2.0)
  • Review
  • Open Access
80 Citations
11,760 Views
16 Pages

21 October 2018

Royal jelly (RJ) is a glandular secretion produced by worker honeybees and is a special food for the queen honeybee. It results in a significant prolongation of the lifespan of the queen honeybee compared with the worker honeybees through anti-inflam...

(This article belongs to the Special Issue The Effect of Dietary Factors on Cancer)
  • Article
  • Open Access
15 Citations
6,404 Views
20 Pages

9 February 2021

Prostate cancer (PCa) is the second most common cancer affecting men worldwide. PCa shows a broad-spectrum heterogeneity in its biological and clinical behavior. Although androgen targeted therapy (ATT) has been the mainstay therapy for advanced PCa,...

(This article belongs to the Special Issue Proteomics in Cancer)
  • Article
  • Open Access
30 Citations
4,762 Views
23 Pages

Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I

  • Malwina Czerwińska,
  • Giulio Fracasso,
  • Marek Pruszyński,
  • Aleksander Bilewicz and ,
  • Marcin Kruszewski,
  • Agnieszka Majkowska-Pilip and
  • Anna Lankoff
  • + 2 authors+ 0 author

2 September 2020

Prostate cancer is the second most frequent malignancy in men worldwide. Unfortunately, current therapies often lead to the onset of metastatic castration-resistant prostate cancer (mCRPC), causing significant mortality. Therefore, there is an urgent...

(This article belongs to the Section Biomaterials)
  • Review
  • Open Access
16 Citations
5,075 Views
10 Pages

Delays in Initiating Anti-Cancer Therapy for Early-Stage Breast Cancer—How Slow Can We Go?

  • Hikmat Abdel-Razeq,
  • Asem Mansour,
  • Sarah Edaily and
  • Abdulmajeed Dayyat

5 July 2023

Breast cancer is the most commonly diagnosed cancer among women worldwide, and is a leading cause of cancer-related deaths. When diagnosed at an early stage, appropriate and timely treatment results in a high cure rate and better quality of life. Del...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
61 Citations
6,501 Views
16 Pages

29 January 2023

Cancer stem cells (CSCs) have been identified and characterized in both hematopoietic and solid tumors. Their existence was first predicted by Virchow and Cohnheim in the 1870s. Later, many studies showed that CSCs can be identified and isolated by t...

(This article belongs to the Special Issue Cancer Metastases: Impact of Epithelial-Mesenchymal Transition, Stem Cell and Microenvironment)
  • Systematic Review
  • Open Access
6 Citations
2,835 Views
13 Pages

Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis

  • István Baradács,
  • Brigitta Teutsch,
  • Ádám Vincze,
  • Péter Hegyi and ,
  • Bence Szabó,
  • Péter Nyirády,
  • Nándor Ács,
  • Zsolt Melczer,
  • Ferenc Bánhidy and
  • Balázs Lintner
  • + 5 authors+ 0 author

6 March 2025

Introduction: Ovarian cancer is a significant contributor to gynecological cancer-related mortality, necessitating innovative treatment strategies. This systematic review and meta-analysis aimed to assess the efficacy and safety of combining PARP inh...

(This article belongs to the Section Obstetrics & Gynecology)
  • Review
  • Open Access
76 Citations
11,364 Views
33 Pages

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer

  • Samson Mathews Samuel,
  • Elizabeth Varghese,
  • Peter Kubatka,
  • Chris R. Triggle and
  • Dietrich Büsselberg

9 December 2019

Interest has grown in studying the possible use of well-known anti-diabetic drugs as anti-cancer agents individually or in combination with, frequently used, chemotherapeutic agents and/or radiation, owing to the fact that diabetes heightens the risk...

(This article belongs to the Special Issue Plant-Derived Natural Compounds in the Management of Cancer: Significance and Challenges)
  • Article
  • Open Access
45 Citations
8,053 Views
20 Pages

Graphene Oxide-Based Targeting of Extracellular Cathepsin D and Cathepsin L As A Novel Anti-Metastatic Enzyme Cancer Therapy

  • Tanveer A. Tabish,
  • Md Zahidul I. Pranjol,
  • David W. Horsell,
  • Alma A. M. Rahat and ,
  • Jacqueline L. Whatmore,
  • Paul G. Winyard and
  • Shaowei Zhang
  • + 2 authors+ 0 author

6 March 2019

Overexpression and secretion of the enzymes cathepsin D (CathD) and cathepsin L (CathL) is associated with metastasis in several human cancers. As a superfamily, extracellularly, these proteins may act within the tumor microenvironment to drive cance...

(This article belongs to the Special Issue Cancer Nanomedicine)
  • Review
  • Open Access
48 Citations
9,080 Views
54 Pages

Importance of Rose Bengal Loaded with Nanoparticles for Anti-Cancer Photodynamic Therapy

  • Batoul Dhaini,
  • Laurène Wagner,
  • Morgane Moinard,
  • Joël Daouk and ,
  • Philippe Arnoux,
  • Hervé Schohn,
  • Perrine Schneller,
  • Samir Acherar,
  • Tayssir Hamieh and
  • Céline Frochot
  • + 5 authors+ 0 author

31 August 2022

Rose Bengal (RB) is a photosensitizer (PS) used in anti-cancer and anti-bacterial photodynamic therapy (PDT). The specific excitation of this PS allows the production of singlet oxygen and oxygen reactive species that kill bacteria and tumor cells. I...

(This article belongs to the Special Issue Photodynamic Therapy 2022)
  • Review
  • Open Access
24 Citations
7,047 Views
15 Pages

Mesenchymal Stem-Cell-Derived Exosomes as Novel Drug Carriers in Anti-Cancer Treatment: A Myth or Reality?

  • Carl Randall Harrell,
  • Ana Volarevic,
  • Valentin Djonov and
  • Vladislav Volarevic

29 January 2025

Although cancer therapy has significantly advanced in recent decades, patients and healthcare professionals are still quite concerned about adverse effects due to the non-targeted nature of currently used chemotherapeutics. Results obtained in a larg...

  • Review
  • Open Access
718 Citations
35,985 Views
39 Pages

Flavonoids in Cancer and Apoptosis

  • Mariam Abotaleb,
  • Samson Mathews Samuel,
  • Elizabeth Varghese,
  • Sharon Varghese and ,
  • Peter Kubatka,
  • Alena Liskova and
  • Dietrich Büsselberg
  • + 2 authors+ 0 author

28 December 2018

Cancer is the second leading cause of death globally. Although, there are many different approaches to cancer treatment, they are often painful due to adverse side effects and are sometimes ineffective due to increasing resistance to classical anti-c...

  • Review
  • Open Access
24 Citations
6,366 Views
24 Pages

24 August 2022

Histone deacetylases (HDACs) regulate gene expression through the epigenetic modification of chromatin structure. HDAC6, unlike many other HDACs, is present in the cytoplasm. Its deacetylates non-histone proteins and plays diverse roles in cancer cel...

(This article belongs to the Special Issue Combating Drug Resistance in Cancer—from Novel Biomarkers to Enhanced Therapeutic Efficacy)
  • Review
  • Open Access
520 Citations
34,001 Views
26 Pages

Gut Microbiota and Cancer: From Pathogenesis to Therapy

  • Silvia Vivarelli,
  • Rossella Salemi,
  • Saverio Candido,
  • Luca Falzone and ,
  • Maria Santagati,
  • Stefania Stefani,
  • Francesco Torino,
  • Giuseppe Luigi Banna,
  • Giuseppe Tonini and
  • Massimo Libra
  • + 5 authors+ 0 author

3 January 2019

Cancer is a multifactorial pathology and it represents the second leading cause of death worldwide. In the recent years, numerous studies highlighted the dual role of the gut microbiota in preserving host’s health. Gut resident bacteria are abl...

  • Article
  • Open Access
3 Citations
5,038 Views
22 Pages

Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models

  • Marlene Schwarzfischer,
  • Maria Rae Walker,
  • Michele Curcio,
  • Nader M. Boshta and ,
  • Arnaud Marchand,
  • Erik Soons,
  • Doris Pöhlmann,
  • Marcin Wawrzyniak,
  • Yasser Morsy and
  • Michael Scharl
  • + 8 authors+ 3 authors

Tumor-associated macrophages (TAMs) in the colorectal cancer (CRC) microenvironment promote tumor progression but can be reprogrammed into a pro-inflammatory state with anti-cancer properties. Activation of the G protein-coupled receptor 84 (GPR84) i...

(This article belongs to the Section Molecular Oncology)

of 194